Safeguard Scientifics, Inc. Common Stock (SFE) Stock

DelistedNasdaq: SFESafeguard Scientifics, Inc.

0.46
Final close · Feb 9, 2024

SFE is no longer traded. Safeguard Scientifics, Inc. Common Stock was delisted from the Nasdaq in February 2024.

Prices on this page are historical; the last trade was February 9, 2024 at $0.46.

Safeguard Scientifics, Inc. Common Stock stock price history

Split-adjusted closes, 1987–2024

SFE final trading statistics

Final close
$0.46
Final trading day
Feb 9, 2024
Market cap at delisting
$7.54M
Shares outstanding
16.58M
Final 52-week range
$0.40 – $3.25
Avg. volume (final 3 mo.)
78,254
All-time high (split-adj.)
$248.60 · Dec 1999
All-time low (split-adj.)
$0.01 · Jan 1985
Return since IPO
+4036.4%
Beta
0.87
Book value / share
$1.81
Price / book
0.25
Final 52 wk
0.403.25

Safeguard Scientifics, Inc. Common Stock earnings per share

Earnings per share

Safeguard Scientifics, Inc. Common Stock revenue & net income

RevenueNet income

Safeguard Scientifics, Inc. Common Stock annual financials

Safeguard Scientifics, Inc. Common Stock revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2023$0.00-$10.3M—
FY2022-$3.30M-$23.8M-$0.06
FY2021$22.04M$46.4M$1.19
FY2020-$7.71M-$34.1M-$1.81
FY2019$12.26M$41.8M$2.65

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Safeguard Scientifics, Inc. Common Stock

Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Sa

Safeguard Scientifics, Inc. Common Stock stock FAQ

What happened to Safeguard Scientifics, Inc. Common Stock stock?

Safeguard Scientifics, Inc. Common Stock stock was delisted from the Nasdaq. Its final close was $0.46 on February 9, 2024.

Is SFE stock still trading?

No. SFE was delisted from the Nasdaq in February 2024 and no longer trades on a U.S. exchange.

What was the last price of SFE stock?

SFE closed at $0.46 on its final trading day, February 9, 2024, for a market value of about $7.54M.

What were Safeguard Scientifics, Inc. Common Stock's revenue and earnings in its last full fiscal year?

Safeguard Scientifics, Inc. Common Stock reported revenue of $0.00 and net income of -$10.3M in fiscal 2023, its last full year as a public company.

When did Safeguard Scientifics, Inc. Common Stock go public?

Safeguard Scientifics, Inc. Common Stock stock began trading on December 30, 1987.

Asset Management stocks to research

All Financial Services stocks →